Product Information
TOVIAZ ER 8 MG TABLET is a brand product labeled by Pfizer Inc., priced at $9.2623 per EA under NDC 00069024430. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 31, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fesoterodine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Pfizer Inc.NDC
00069024430
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022030FDA Approved
10/31/2008
TE Code
AB
On Market Since
10/31/2008
Price Statistics
The NADAC for TOVIAZ ER 8 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 71.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2623 per EA |
|---|---|
| All-time high | $12.0544 (Nov 29, 2023) |
| All-time low | $5.4142 (Nov 28, 2013) |
| 52-week high | $9.2812 |
| 52-week low | $9.2596 |
| Median price | $9.5534 |
| Average price | $9.6594 |
| Largest weekly change | -23.0% (Dec 6, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fesoterodine fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOVIAZ ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOVIAZ ER 8 MG TABLET, manufactured by Pfizer Inc., is $9.2623 per EA (NDC 00069024430), effective Sep 30, 2026.
How has the price of TOVIAZ ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOVIAZ ER 8 MG TABLET has risen 71.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOVIAZ ER 8 MG TABLET?
Since Nov 28, 2013, the NADAC for TOVIAZ ER 8 MG TABLET has ranged from a low of $5.4142 (Nov 28, 2013) to a high of $12.0544 (Nov 29, 2023), with a median of $9.5534 per EA.
Are there cheaper alternatives to TOVIAZ ER 8 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FESOTERODINE ER 8 MG TABLET, is $0.8393 per EA — about 91% below TOVIAZ ER 8 MG TABLET.
Who manufactures TOVIAZ ER 8 MG TABLET?
TOVIAZ ER 8 MG TABLET (NDC 00069024430) is labeled by Pfizer Inc., and CMS classifies it as a brand product.